Purchase Order 75N91019P00260

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for the Oncomine Comprehensive Manual Combo Kit (catalog A35805) valued at $17,100.00, with an award date of August 6, 2018 and completion date of September 30, 2018. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Oncomine Comprehensive Manual Combo Kit (catalog A35805) valued at $17,100.00 on August 7, 2018, with completion by September 30, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $17,100 on December 19, 2018, for an Oncomine Comprehensive V3M Combo Kit (catalog# A35805), with ultimate completion on January 31, 2019. Place of performance is Grand Island, New York. Life Technologies is a wholly owned subsidiary of Thermo Fisher Scientific and competes without small-business certifications. The order carries firm fixed-price pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation for biological kits valued at $13,697.04, awarded July 9, 2019, with ultimate completion August 8, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price commercial item pricing with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for ION 540 chip kits at $13,504.05 on April 2, 2019, with completion due May 2, 2019. Performance occurs at the vendor's Carlsbad, California facility. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $20,776.50 on September 5, 2019, with completion by October 5, 2019. Place of performance is Carlsbad, California. The order represents a firm fixed-price, commercial purchase of laboratory instrumentation, reagents, or consumables—Life Technologies' core federal offering in genetic analysis and molecular biology. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $10,146.00 on July 25, 2017, for laboratory supplies with ultimate completion on August 23, 2017. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $19,953.15 on July 26, 2017, for lab supplies with firm fixed pricing and no set-aside designation. Place of performance is Carlsbad, California. The order completes on August 24, 2017.</p>